Fluorescence-Guided Optimization of Sarcoma Margins

Recruiting now · Not applicable

Conditions studied: Soft Tissue Sarcoma of the Trunk and Extremities, Sarcoma

In brief

This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.

Key facts

Study ID

NCT07134192

Run by

University of Aarhus

People needed

90

Starts

2025-09-01

Expected to finish

2028-03-01

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall
• Age>18 years old
• Tumor operable
• Curative intent at time of surgery
• Consent of patient

You may not qualify if…

• History of allergic reaction to iodine-containing pharmaceuticals
• End-stage renal disease or eGFR <15
• Patient decision
• Lack of capacity
• Inoperability

Where it is running

• Aarhus University Hospital — Aarhus N, Denmark (enrolling)
• Rigshospitalet — Copenhagen, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.